The effectiveness and value of fezolinetant for moderate-to-severe vasomotor symptoms associated with menopause: A summary from the Institute for Clinical and Economic Review’s Midwest Public Advisory Council

Detalles Bibliográficos
Autores principales: Wright, Abigail C, Beaudoin, Francesca L, McQueen, R. Brett, Yeung, Kai, Moradi, Ashton, Herron-Smith, Serina, Gutierrez, Eric, Lin, Grace A, Pearson, Steven D
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Academy of Managed Care Pharmacy 2023
Materias:
Perspectives on Value
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10387909/
https://www.ncbi.nlm.nih.gov/pubmed/37276043
http://dx.doi.org/10.18553/jmcp.2023.29.6.692
Descripción
Sumario:

Ejemplares similares